drugset / Trial / NCT01611584

A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer

NCT01611584

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this trial is to measure ALA-induced fluorescence in both normal and malignant tissue.

Timeline

Start
2010-06
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent 20 mg/kg

Indications